CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients (Q37349172)

From Wikidata

Jump to navigation Jump to search

scientific article published on September 2008

edit

Language	Label	Description	Also known as
English	CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients	scientific article published on September 2008

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

title

CD4 T cell survival after intermittent interleukin-2 therapy is predictive of an increase in the CD4 T cell count of HIV-infected patients (English)

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

main subject

interleukins

0 references

author

Irini Sereti

object named as

Irini Sereti

series ordinal

9

0 references

Richard A. Lempicki

object named as

Richard A Lempicki

series ordinal

2

0 references

Marjorie Bosche

series ordinal

7

object named as

Marjorie Bosche

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Joseph W Adelsberger

series ordinal

8

object named as

Joseph W Adelsberger

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

author name string

Sarah W Read

series ordinal

1

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Michele Di Mascio

series ordinal

3

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Sharat Srinivasula

series ordinal

4

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Rosanne Burke

series ordinal

5

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

William Sachau

series ordinal

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Richard T Davey

series ordinal

10

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Jorge A Tavel

series ordinal

11

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Chiung-Yu Huang

series ordinal

12

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Haleem J Issaq

series ordinal

13

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Stephen D Fox

series ordinal

14

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

H Clifford Lane

series ordinal

15

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

Joseph A Kovacs

series ordinal

16

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

language of work or name

English

0 references

publication date

1 September 2008

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

published in

Journal of Infectious Diseases

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

volume

198

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

issue

6

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

page(s)

843-850

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

cites work

Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

6 September 2017

In vivo expansion of CD4CD45RO-CD25 T cells expressing foxP3 in IL-2-treated HIV-infected patients

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

6 September 2017

IL-2-induced CD4+ T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

6 September 2017

Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

6 September 2017

Measurement of T-cell kinetics: recent methodologic advances

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

6 September 2017

Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

14 September 2017

A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infection

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

26 June 2018

Modeling deuterated glucose labeling of T-lymphocytes

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

2 September 2018

Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: a randomised controlled trial. ANRS 048 study group.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

2 September 2018

Predictors of CD4 count change over 8 months of follow up in HIV-1-infected patients with a CD4 count?300 cells/?L who were assigned to 7.5 MIU interleukin-2

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2744986

retrieved

3 December 2018

CD4+T Cell Responses to Interleukin‐2 Administration in HIV‐Infected Patients Are Directly Related to the Baseline Level of Immune Activation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18684102

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term effects of intermittent interleukin 2 therapy in patients with HIV infection: characterization of a novel subset of CD4(+)/CD25(+) T cells

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18684102

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized controlled trial evaluating the efficacy and safety of intermittent 3-, 4-, and 5-day cycles of intravenous recombinant human interleukin-2 combined with antiretroviral therapy (ART) versus ART alone in HIV-seropositive patients with 10

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18684102

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nadir CD4+ T Cell Count Predicts Response to Subcutaneous Recombinant Interleukin-2

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18684102

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/18684102

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1086/591250

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

PMC publication ID

2744986

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

PubMed publication ID

18684102

1 reference

stated in

Europe PubMed Central

PMC publication ID

2744986

retrieved

19 August 2017

ResearchGate publication ID

23153056

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37349172&oldid=2125986568"